About
L1 Page Founded in 2017, Echo biotech is an innovative high-tech company focused on exosome technology development and clinical translation, with proprietary Exoomics®, Echosome®, and EchoPharm® platforms.
Quick Facts
- L1 Page
- Founded in 2017, Echo biotech is an innovative high-tech company focused on exosome technology development and clinical translation, with proprietary Exoomics®, Echosome®, and Ech…
Company Profile
Founded in 2017, Echo biotech is an innovative high-tech company focused on exosome technology development and clinical translation, with proprietary Exoomics®, Echosome®, and EchoPharm® platforms.
The company has completed multiple financing rounds, established a 3000+ m² GMP production facility, and collaborated with hospitals, research institutions, and biotech partners, co-publishing 300+ papers and processing 80,000+ samples.
Echo biotech is committed to comprehensive exosome regenerative medicine and systemic anti-aging solutions through continuous innovation and strict quality standards.